aluates Reports

$ 0.0

Automative

Global Traveler's Diarrhea Therapeutics Market Research Report 2026

Published Date: 2026-03-03

Report Code: QYRE-Auto-11I13103

Global Traveler s Diarrhea Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Traveler's Diarrhea Therapeutics Market Research Report 2026

Code: QYRE-Auto-11I13103

Report

2026-03-03

Pages:113

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

P&G

Johnson & Johnson

Otsuka Pharma

Valneva

Shanghai United Cell

PaxVax

LIVZON

Immuron

P&G

Johnson & Johnson

Bausch Health

Traveler's Diarrhea Therapeutics Market Size

The global Traveler's Diarrhea Therapeutics market was valued at US$ 1018 million in 2025 and is anticipated to reach US$ 1635 million by 2032, at a CAGR of 7.1% from 2026 to 2032.

Traveler's Diarrhea Therapeutics Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Traveler's Diarrhea Therapeutics competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Traveler’s Diarrhea Therapeutics refer to a class of medications designed to prevent, alleviate, and treat acute diarrheal syndromes caused by foodborne or waterborne pathogens. This condition commonly affects international travelers, military personnel, business delegates, and humanitarian workers, with major causative agents including enterotoxigenic Escherichia coli (ETEC), Salmonella, Shigella, Vibrio, and Norovirus. Therapeutic options include antibiotics (such as fluoroquinolones and rifaximin), antisecretory agents, antidiarrheals (like loperamide), probiotics, and emerging vaccines or immune-modulatory therapies. The development of traveler’s diarrhea therapeutics is evolving from single-drug interventions to integrated, personalized, microbiota- and immunity-oriented strategies to improve efficacy and reduce antimicrobial resistance.In 2024, global Traveler’s Diarrhea Therapeutics production reached approximately 85.73 m units, with an average global market price of around US$ 11 perunit.The average gross profit margin of this product is 45%.

The increasing global mobility and resurgence of international tourism have driven steady growth in the traveler’s diarrhea therapeutics market. With the revival of the travel industry, business trips, and military deployments, this condition remains one of the most common travel-related health issues. Rising demand for fast-acting, safe, and low-resistance therapies has spurred the development of non-antibiotic treatments and microbiome-based interventions. Moreover, the growing emphasis on travel medicine and infection prevention by public health authorities worldwide is fostering research and innovation in therapeutics and vaccine development.

The industry faces key challenges such as escalating antibiotic resistance, increasingly stringent regulatory requirements, and poor patient compliance. Overreliance on antibacterial drugs has led to the proliferation of resistant strains, undermining traditional treatments. New drug candidates must meet higher safety and efficacy standards, prolonging development timelines. In addition, inadequate adherence or inappropriate use of medication among travelers contributes to suboptimal outcomes and higher complication risks. Regional variations in pathogen prevalence further complicate drug adaptability, creating uncertainty for companies expanding into global markets.

Downstream demand is becoming increasingly diversified. Clinicians are prioritizing combination therapies and microbiome modulation approaches that deliver rapid relief while minimizing antimicrobial resistance. Consumers show growing preference for convenient, portable, and safe over-the-counter (OTC) drugs and probiotic-based products. The expansion of digital health and telemedicine enables travelers to access personalized preventive and therapeutic guidance during trips. Industry players are transitioning from single-drug treatments to integrated “prevention–intervention–recovery” solutions aligned with holistic travel health management trends.

Upstream production of traveler’s diarrhea therapeutics primarily involves active pharmaceutical ingredients (APIs) and excipients, including antibacterial agents (e.g., rifaximin, azithromycin), antidiarrheal compounds, probiotic strains, and encapsulation carriers. Manufacturing requires high standards of purity, stability, and traceability, with increasingly rigorous quality control for microbial products. As the market shifts toward non-antibiotic and biologically derived therapies, new raw materials—such as natural extracts, probiotics, and synthetic peptides—are becoming R&D focal points. However, heavy reliance on international supply chains makes production costs and delivery timelines highly sensitive to geopolitical and trade policy fluctuations.

This report delivers a comprehensive overview of the global Traveler's Diarrhea Therapeutics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Traveler's Diarrhea Therapeutics. The Traveler's Diarrhea Therapeutics market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Traveler's Diarrhea Therapeutics market comprehensively. Regional market sizes by Type, by Application, by Pathogen Type, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Traveler's Diarrhea Therapeutics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Traveler's Diarrhea Therapeutics Market Report

Report Metric	Details
Report Name	Traveler's Diarrhea Therapeutics Market
Accounted market size in 2025	US$ 1018 in million
Forecasted market size in 2032	US$ 1635 million
CAGR	7.1%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Immunization Non-antibiotic Agents Antibiotics Anti-Motility Agents Others
Segment by Pathogen Type	Bacterial TD Viral TD
Segment by Route of Administration	Oral Formulations Injectable Formulations Topical or Local Delivery
by Application	Adult Traveler's Diarrhea Children Traveler's Diarrhea
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Bausch Health, P&G, Johnson & Johnson, Otsuka Pharma, Valneva, Shanghai United Cell, PaxVax, Livzon, Immuron
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Pathogen Type, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Traveler's Diarrhea Therapeutics manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Traveler's Diarrhea Therapeutics sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Traveler's Diarrhea Therapeutics Market growing?

Ans: The Traveler's Diarrhea Therapeutics Market witnessing a CAGR of 7.1% during the forecast period 2026-2032.

What is the Traveler's Diarrhea Therapeutics Market size in 2032?

Ans: The Traveler's Diarrhea Therapeutics Market size in 2032 will be US$ 1635 million.

Who are the main players in the Traveler's Diarrhea Therapeutics Market report?

Ans: The main players in the Traveler's Diarrhea Therapeutics Market are Bausch Health, P&G, Johnson & Johnson, Otsuka Pharma, Valneva, Shanghai United Cell, PaxVax, Livzon, Immuron

What are the Application segmentation covered in the Traveler's Diarrhea Therapeutics Market report?

Ans: The Applications covered in the Traveler's Diarrhea Therapeutics Market report are Adult Traveler's Diarrhea, Children Traveler's Diarrhea

What are the Type segmentation covered in the Traveler's Diarrhea Therapeutics Market report?

Ans: The Types covered in the Traveler's Diarrhea Therapeutics Market report are Bacterial TD, Viral TD

1 Traveler's Diarrhea Therapeutics Market Overview

1.1 Product Definition

1.2 Traveler's Diarrhea Therapeutics by Type

1.2.1 Global Traveler's Diarrhea Therapeutics Market Value by Type: 2025 vs 2032

1.2.2 Immunization

1.2.3 Non-antibiotic Agents

1.2.4 Antibiotics

1.2.5 Anti-Motility Agents

1.2.6 Others

1.3 Traveler's Diarrhea Therapeutics by Pathogen Type

1.3.1 Global Traveler's Diarrhea Therapeutics Market Value by Pathogen Type: 2025 vs 2032

1.3.2 Bacterial TD

1.3.3 Viral TD

1.4 Traveler's Diarrhea Therapeutics by Route of Administration

1.4.1 Global Traveler's Diarrhea Therapeutics Market Value by Route of Administration: 2025 vs 2032

1.4.2 Oral Formulations

1.4.3 Injectable Formulations

1.4.4 Topical or Local Delivery

1.5 Traveler's Diarrhea Therapeutics by Application

1.5.1 Global Traveler's Diarrhea Therapeutics Market Value by Application: 2025 vs 2032

1.5.2 Adult Traveler's Diarrhea

1.5.3 Children Traveler's Diarrhea

1.6 Global Traveler's Diarrhea Therapeutics Market Size Estimates and Forecasts

1.6.1 Global Traveler's Diarrhea Therapeutics Revenue 2021–2032

1.6.2 Global Traveler's Diarrhea Therapeutics Sales 2021–2032

1.6.3 Global Traveler's Diarrhea Therapeutics Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2 Traveler's Diarrhea Therapeutics Market Competition by Manufacturers

2.1 Global Traveler's Diarrhea Therapeutics Sales Market Share by Manufacturers (2021–2026)

2.2 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Traveler's Diarrhea Therapeutics Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Traveler's Diarrhea Therapeutics, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Traveler's Diarrhea Therapeutics, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Traveler's Diarrhea Therapeutics, Product Types and Applications

2.7 Global Key Manufacturers of Traveler's Diarrhea Therapeutics, Date of Entry into the Industry

2.8 Global Traveler's Diarrhea Therapeutics Market Competitive Situation and Trends

2.8.1 Global Traveler's Diarrhea Therapeutics Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Traveler's Diarrhea Therapeutics Players Market Share by Revenue

2.8.3 Global Traveler's Diarrhea Therapeutics Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Traveler's Diarrhea Therapeutics Market Scenario by Region

3.1 Global Traveler's Diarrhea Therapeutics Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Traveler's Diarrhea Therapeutics Sales by Region: 2021–2032

3.2.1 Global Traveler's Diarrhea Therapeutics Sales by Region: 2021–2026

3.2.2 Global Traveler's Diarrhea Therapeutics Sales by Region: 2027–2032

3.3 Global Traveler's Diarrhea Therapeutics Revenue by Region: 2021–2032

3.3.1 Global Traveler's Diarrhea Therapeutics Revenue by Region: 2021–2026

3.3.2 Global Traveler's Diarrhea Therapeutics Revenue by Region: 2027–2032

3.4 North America Traveler's Diarrhea Therapeutics Market Facts & Figures by Country

3.4.1 North America Traveler's Diarrhea Therapeutics Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Traveler's Diarrhea Therapeutics Sales by Country (2021–2032)

3.4.3 North America Traveler's Diarrhea Therapeutics Revenue by Country (2021–2032)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Traveler's Diarrhea Therapeutics Market Facts & Figures by Country

3.5.1 Europe Traveler's Diarrhea Therapeutics Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Traveler's Diarrhea Therapeutics Sales by Country (2021–2032)

3.5.3 Europe Traveler's Diarrhea Therapeutics Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Traveler's Diarrhea Therapeutics Market Facts & Figures by Region

3.6.1 Asia Pacific Traveler's Diarrhea Therapeutics Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Traveler's Diarrhea Therapeutics Sales by Region (2021–2032)

3.6.3 Asia Pacific Traveler's Diarrhea Therapeutics Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Traveler's Diarrhea Therapeutics Market Facts & Figures by Country

3.7.1 Latin America Traveler's Diarrhea Therapeutics Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Traveler's Diarrhea Therapeutics Sales by Country (2021–2032)

3.7.3 Latin America Traveler's Diarrhea Therapeutics Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Traveler's Diarrhea Therapeutics Market Facts & Figures by Country

3.8.1 Middle East and Africa Traveler's Diarrhea Therapeutics Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Country (2021–2032)

3.8.3 Middle East and Africa Traveler's Diarrhea Therapeutics Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Traveler's Diarrhea Therapeutics Sales by Type (2021–2032)

4.1.1 Global Traveler's Diarrhea Therapeutics Sales by Type (2021–2026)

4.1.2 Global Traveler's Diarrhea Therapeutics Sales by Type (2027–2032)

4.1.3 Global Traveler's Diarrhea Therapeutics Sales Market Share by Type (2021–2032)

4.2 Global Traveler's Diarrhea Therapeutics Revenue by Type (2021–2032)

4.2.1 Global Traveler's Diarrhea Therapeutics Revenue by Type (2021–2026)

4.2.2 Global Traveler's Diarrhea Therapeutics Revenue by Type (2027–2032)

4.2.3 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Type (2021–2032)

4.3 Global Traveler's Diarrhea Therapeutics Price by Type (2021–2032)

5 Segment by Application

5.1 Global Traveler's Diarrhea Therapeutics Sales by Application (2021–2032)

5.1.1 Global Traveler's Diarrhea Therapeutics Sales by Application (2021–2026)

5.1.2 Global Traveler's Diarrhea Therapeutics Sales by Application (2027–2032)

5.1.3 Global Traveler's Diarrhea Therapeutics Sales Market Share by Application (2021–2032)

5.2 Global Traveler's Diarrhea Therapeutics Revenue by Application (2021–2032)

5.2.1 Global Traveler's Diarrhea Therapeutics Revenue by Application (2021–2026)

5.2.2 Global Traveler's Diarrhea Therapeutics Revenue by Application (2027–2032)

5.2.3 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Application (2021–2032)

5.3 Global Traveler's Diarrhea Therapeutics Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Bausch Health

6.1.1 Bausch Health Company Information

6.1.2 Bausch Health Description and Business Overview

6.1.3 Bausch Health Traveler's Diarrhea Therapeutics Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Bausch Health Traveler's Diarrhea Therapeutics Product Portfolio

6.1.5 Bausch Health Recent Developments/Updates

6.2 P&G

6.2.1 P&G Company Information

6.2.2 P&G Description and Business Overview

6.2.3 P&G Traveler's Diarrhea Therapeutics Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 P&G Traveler's Diarrhea Therapeutics Product Portfolio

6.2.5 P&G Recent Developments/Updates

6.3 Johnson & Johnson

6.3.1 Johnson & Johnson Company Information

6.3.2 Johnson & Johnson Description and Business Overview

6.3.3 Johnson & Johnson Traveler's Diarrhea Therapeutics Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Johnson & Johnson Traveler's Diarrhea Therapeutics Product Portfolio

6.3.5 Johnson & Johnson Recent Developments/Updates

6.4 Otsuka Pharma

6.4.1 Otsuka Pharma Company Information

6.4.2 Otsuka Pharma Description and Business Overview

6.4.3 Otsuka Pharma Traveler's Diarrhea Therapeutics Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Otsuka Pharma Traveler's Diarrhea Therapeutics Product Portfolio

6.4.5 Otsuka Pharma Recent Developments/Updates

6.5 Valneva

6.5.1 Valneva Company Information

6.5.2 Valneva Description and Business Overview

6.5.3 Valneva Traveler's Diarrhea Therapeutics Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Valneva Traveler's Diarrhea Therapeutics Product Portfolio

6.5.5 Valneva Recent Developments/Updates

6.6 Shanghai United Cell

6.6.1 Shanghai United Cell Company Information

6.6.2 Shanghai United Cell Description and Business Overview

6.6.3 Shanghai United Cell Traveler's Diarrhea Therapeutics Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Shanghai United Cell Traveler's Diarrhea Therapeutics Product Portfolio

6.6.5 Shanghai United Cell Recent Developments/Updates

6.7 PaxVax

6.7.1 PaxVax Company Information

6.7.2 PaxVax Description and Business Overview

6.7.3 PaxVax Traveler's Diarrhea Therapeutics Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 PaxVax Traveler's Diarrhea Therapeutics Product Portfolio

6.7.5 PaxVax Recent Developments/Updates

6.8 Livzon

6.8.1 Livzon Company Information

6.8.2 Livzon Description and Business Overview

6.8.3 Livzon Traveler's Diarrhea Therapeutics Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Livzon Traveler's Diarrhea Therapeutics Product Portfolio

6.8.5 Livzon Recent Developments/Updates

6.9 Immuron

6.9.1 Immuron Company Information

6.9.2 Immuron Description and Business Overview

6.9.3 Immuron Traveler's Diarrhea Therapeutics Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Immuron Traveler's Diarrhea Therapeutics Product Portfolio

6.9.5 Immuron Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Traveler's Diarrhea Therapeutics Industry Chain Analysis

7.2 Traveler's Diarrhea Therapeutics Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Traveler's Diarrhea Therapeutics Production Mode & Process Analysis

7.4 Traveler's Diarrhea Therapeutics Sales and Marketing

7.4.1 Traveler's Diarrhea Therapeutics Sales Channels

7.4.2 Traveler's Diarrhea Therapeutics Distributors

7.5 Traveler's Diarrhea Therapeutics Customer Analysis

8 Traveler's Diarrhea Therapeutics Market Dynamics

8.1 Traveler's Diarrhea Therapeutics Industry Trends

8.2 Traveler's Diarrhea Therapeutics Market Drivers

8.3 Traveler's Diarrhea Therapeutics Market Challenges

8.4 Traveler's Diarrhea Therapeutics Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

P&G

Johnson & Johnson

Otsuka Pharma

Valneva

Shanghai United Cell

PaxVax

LIVZON

Immuron

P&G

Johnson & Johnson

Bausch Health

List of Tables

Table 1. Global Traveler's Diarrhea Therapeutics Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Traveler's Diarrhea Therapeutics Market Value by Pathogen Type (US$ Million), 2025 vs 2032

Table 3. Global Traveler's Diarrhea Therapeutics Market Value by Route of Administration (US$ Million), 2025 vs 2032

Table 4. Global Traveler's Diarrhea Therapeutics Market Value by Application (US$ Million), 2025 vs 2032

Table 5. Global Traveler's Diarrhea Therapeutics Market Competitive Situation by Manufacturers in 2025

Table 6. Global Traveler's Diarrhea Therapeutics Sales (K Units) of Key Manufacturers (2021–2026)

Table 7. Global Traveler's Diarrhea Therapeutics Sales Market Share by Manufacturers (2021–2026)

Table 8. Global Traveler's Diarrhea Therapeutics Revenue (US$ Million) by Manufacturers (2021–2026)

Table 9. Global Traveler's Diarrhea Therapeutics Revenue Share by Manufacturers (2021–2026)

Table 10. Global Market Traveler's Diarrhea Therapeutics Average Price (USD/Unit) of Key Manufacturers (2021–2026)

Table 11. Global Key Players of Traveler's Diarrhea Therapeutics, Industry Ranking, 2023 vs 2024 vs 2025

Table 12. Global Key Manufacturers of Traveler's Diarrhea Therapeutics, Manufacturing Sites and Headquarters

Table 13. Global Key Manufacturers of Traveler's Diarrhea Therapeutics, Product Types and Applications

Table 14. Global Key Manufacturers of Traveler's Diarrhea Therapeutics, Date of Entry into the Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Traveler's Diarrhea Therapeutics Companies by Tier (Tier 1, Tier 2, Tier 3), based on Traveler's Diarrhea Therapeutics Revenue, 2025

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Traveler's Diarrhea Therapeutics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Traveler's Diarrhea Therapeutics Sales by Region (K Units), 2021–2026

Table 20. Global Traveler's Diarrhea Therapeutics Sales Market Share by Region (2021–2026)

Table 21. Global Traveler's Diarrhea Therapeutics Sales by Region (K Units), 2027–2032

Table 22. Global Traveler's Diarrhea Therapeutics Sales Market Share by Region (2027–2032)

Table 23. Global Traveler's Diarrhea Therapeutics Revenue by Region (US$ Million), 2021–2026

Table 24. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Region (2021–2026)

Table 25. Global Traveler's Diarrhea Therapeutics Revenue by Region (US$ Million), 2027–2032

Table 26. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Region (2027–2032)

Table 27. North America Traveler's Diarrhea Therapeutics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 28. North America Traveler's Diarrhea Therapeutics Sales by Country (K Units), 2021–2026

Table 29. North America Traveler's Diarrhea Therapeutics Sales by Country (K Units), 2027–2032

Table 30. North America Traveler's Diarrhea Therapeutics Revenue by Country (US$ Million), 2021–2026

Table 31. North America Traveler's Diarrhea Therapeutics Revenue by Country (US$ Million), 2027–2032

Table 32. Europe Traveler's Diarrhea Therapeutics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 33. Europe Traveler's Diarrhea Therapeutics Sales by Country (K Units), 2021–2026

Table 34. Europe Traveler's Diarrhea Therapeutics Sales by Country (K Units), 2027–2032

Table 35. Europe Traveler's Diarrhea Therapeutics Revenue by Country (US$ Million), 2021–2026

Table 36. Europe Traveler's Diarrhea Therapeutics Revenue by Country (US$ Million), 2027–2032

Table 37. Asia Pacific Traveler's Diarrhea Therapeutics Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 38. Asia Pacific Traveler's Diarrhea Therapeutics Sales by Region (K Units), 2021–2026

Table 39. Asia Pacific Traveler's Diarrhea Therapeutics Sales by Region (K Units), 2027–2032

Table 40. Asia Pacific Traveler's Diarrhea Therapeutics Revenue by Region (US$ Million), 2021–2026

Table 41. Asia Pacific Traveler's Diarrhea Therapeutics Revenue by Region (US$ Million), 2027–2032

Table 42. Latin America Traveler's Diarrhea Therapeutics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 43. Latin America Traveler's Diarrhea Therapeutics Sales by Country (K Units), 2021–2026

Table 44. Latin America Traveler's Diarrhea Therapeutics Sales by Country (K Units), 2027–2032

Table 45. Latin America Traveler's Diarrhea Therapeutics Revenue by Country (US$ Million), 2021–2026

Table 46. Latin America Traveler's Diarrhea Therapeutics Revenue by Country (US$ Million), 2027–2032

Table 47. Middle East and Africa Traveler's Diarrhea Therapeutics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 48. Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Country (K Units), 2021–2026

Table 49. Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Country (K Units), 2027–2032

Table 50. Middle East and Africa Traveler's Diarrhea Therapeutics Revenue by Country (US$ Million), 2021–2026

Table 51. Middle East and Africa Traveler's Diarrhea Therapeutics Revenue by Country (US$ Million), 2027–2032

Table 52. Global Traveler's Diarrhea Therapeutics Sales (K Units) by Type (2021–2026)

Table 53. Global Traveler's Diarrhea Therapeutics Sales (K Units) by Type (2027–2032)

Table 54. Global Traveler's Diarrhea Therapeutics Sales Market Share by Type (2021–2026)

Table 55. Global Traveler's Diarrhea Therapeutics Sales Market Share by Type (2027–2032)

Table 56. Global Traveler's Diarrhea Therapeutics Revenue (US$ Million) by Type (2021–2026)

Table 57. Global Traveler's Diarrhea Therapeutics Revenue (US$ Million) by Type (2027–2032)

Table 58. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Type (2021–2026)

Table 59. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Type (2027–2032)

Table 60. Global Traveler's Diarrhea Therapeutics Price (USD/Unit) by Type (2021–2026)

Table 61. Global Traveler's Diarrhea Therapeutics Price (USD/Unit) by Type (2027–2032)

Table 62. Global Traveler's Diarrhea Therapeutics Sales (K Units) by Application (2021–2026)

Table 63. Global Traveler's Diarrhea Therapeutics Sales (K Units) by Application (2027–2032)

Table 64. Global Traveler's Diarrhea Therapeutics Sales Market Share by Application (2021–2026)

Table 65. Global Traveler's Diarrhea Therapeutics Sales Market Share by Application (2027–2032)

Table 66. Global Traveler's Diarrhea Therapeutics Revenue (US$ Million) by Application (2021–2026)

Table 67. Global Traveler's Diarrhea Therapeutics Revenue (US$ Million) by Application (2027–2032)

Table 68. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Application (2021–2026)

Table 69. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Application (2027–2032)

Table 70. Global Traveler's Diarrhea Therapeutics Price (USD/Unit) by Application (2021–2026)

Table 71. Global Traveler's Diarrhea Therapeutics Price (USD/Unit) by Application (2027–2032)

Table 72. Bausch Health Company Information

Table 73. Bausch Health Description and Business Overview

Table 74. Bausch Health Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 75. Bausch Health Traveler's Diarrhea Therapeutics Product

Table 76. Bausch Health Recent Developments/Updates

Table 77. P&G Company Information

Table 78. P&G Description and Business Overview

Table 79. P&G Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 80. P&G Traveler's Diarrhea Therapeutics Product

Table 81. P&G Recent Developments/Updates

Table 82. Johnson & Johnson Company Information

Table 83. Johnson & Johnson Description and Business Overview

Table 84. Johnson & Johnson Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 85. Johnson & Johnson Traveler's Diarrhea Therapeutics Product

Table 86. Johnson & Johnson Recent Developments/Updates

Table 87. Otsuka Pharma Company Information

Table 88. Otsuka Pharma Description and Business Overview

Table 89. Otsuka Pharma Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 90. Otsuka Pharma Traveler's Diarrhea Therapeutics Product

Table 91. Otsuka Pharma Recent Developments/Updates

Table 92. Valneva Company Information

Table 93. Valneva Description and Business Overview

Table 94. Valneva Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 95. Valneva Traveler's Diarrhea Therapeutics Product

Table 96. Valneva Recent Developments/Updates

Table 97. Shanghai United Cell Company Information

Table 98. Shanghai United Cell Description and Business Overview

Table 99. Shanghai United Cell Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 100. Shanghai United Cell Traveler's Diarrhea Therapeutics Product

Table 101. Shanghai United Cell Recent Developments/Updates

Table 102. PaxVax Company Information

Table 103. PaxVax Description and Business Overview

Table 104. PaxVax Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 105. PaxVax Traveler's Diarrhea Therapeutics Product

Table 106. PaxVax Recent Developments/Updates

Table 107. Livzon Company Information

Table 108. Livzon Description and Business Overview

Table 109. Livzon Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 110. Livzon Traveler's Diarrhea Therapeutics Product

Table 111. Livzon Recent Developments/Updates

Table 112. Immuron Company Information

Table 113. Immuron Description and Business Overview

Table 114. Immuron Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 115. Immuron Traveler's Diarrhea Therapeutics Product

Table 116. Immuron Recent Developments/Updates

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Traveler's Diarrhea Therapeutics Distributors List

Table 120. Traveler's Diarrhea Therapeutics Customers List

Table 121. Traveler's Diarrhea Therapeutics Market Trends

Table 122. Traveler's Diarrhea Therapeutics Market Drivers

Table 123. Traveler's Diarrhea Therapeutics Market Challenges

Table 124. Traveler's Diarrhea Therapeutics Market Restraints

Table 125. Research Programs/Design for This Report

Table 126. Key Data Information from Secondary Sources

Table 127. Key Data Information from Primary Sources

Table 128. Authors List of This Report

List of Figures

Figure 1. Product Picture of Traveler's Diarrhea Therapeutics

Figure 2. Global Traveler's Diarrhea Therapeutics Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Traveler's Diarrhea Therapeutics Market Share by Type: 2025 & 2032

Figure 4. Immunization Product Picture

Figure 5. Non-antibiotic Agents Product Picture

Figure 6. Antibiotics Product Picture

Figure 7. Anti-Motility Agents Product Picture

Figure 8. Others Product Picture

Figure 9. Global Traveler's Diarrhea Therapeutics Market Value by Pathogen Type (US$ Million), 2021–2032

Figure 10. Global Traveler's Diarrhea Therapeutics Market Share by Pathogen Type: 2025 vs 2032

Figure 11. Bacterial TD Product Picture

Figure 12. Viral TD Product Picture

Figure 13. Global Traveler's Diarrhea Therapeutics Market Value by Route of Administration (US$ Million), 2021–2032

Figure 14. Global Traveler's Diarrhea Therapeutics Market Share by Route of Administration: 2025 vs 2032

Figure 15. Oral Formulations Product Picture

Figure 16. Injectable Formulations Product Picture

Figure 17. Topical or Local Delivery Product Picture

Figure 18. Global Traveler's Diarrhea Therapeutics Market Value by Application (US$ Million), 2021–2032

Figure 19. Global Traveler's Diarrhea Therapeutics Market Share by Application: 2025 & 2032

Figure 20. Adult Traveler's Diarrhea

Figure 21. Children Traveler's Diarrhea

Figure 22. Global Traveler's Diarrhea Therapeutics Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 23. Global Traveler's Diarrhea Therapeutics Market Size (US$ Million), 2021–2032

Figure 24. Global Traveler's Diarrhea Therapeutics Sales (K Units), 2021–2032

Figure 25. Global Traveler's Diarrhea Therapeutics Average Price (USD/Unit), 2021–2032

Figure 26. Traveler's Diarrhea Therapeutics Report Years Considered

Figure 27. Traveler's Diarrhea Therapeutics Sales Share by Manufacturers in 2025

Figure 28. Global Traveler's Diarrhea Therapeutics Revenue Share by Manufacturers in 2025

Figure 29. Top 5 and Top 10 Global Traveler's Diarrhea Therapeutics Players: Market Share by Revenue in Traveler's Diarrhea Therapeutics in 2025

Figure 30. Traveler's Diarrhea Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 31. Global Traveler's Diarrhea Therapeutics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 32. North America Traveler's Diarrhea Therapeutics Sales Market Share by Country (2021–2032)

Figure 33. North America Traveler's Diarrhea Therapeutics Revenue Market Share by Country (2021–2032)

Figure 34. U.S. Traveler's Diarrhea Therapeutics Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Canada Traveler's Diarrhea Therapeutics Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Country (2021–2032)

Figure 37. Europe Traveler's Diarrhea Therapeutics Revenue Market Share by Country (2021–2032)

Figure 38. Germany Traveler's Diarrhea Therapeutics Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. France Traveler's Diarrhea Therapeutics Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. U.K. Traveler's Diarrhea Therapeutics Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Italy Traveler's Diarrhea Therapeutics Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Russia Traveler's Diarrhea Therapeutics Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Asia Pacific Traveler's Diarrhea Therapeutics Sales Market Share by Region (2021–2032)

Figure 44. Asia Pacific Traveler's Diarrhea Therapeutics Revenue Market Share by Region (2021–2032)

Figure 45. China Traveler's Diarrhea Therapeutics Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Japan Traveler's Diarrhea Therapeutics Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. South Korea Traveler's Diarrhea Therapeutics Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. India Traveler's Diarrhea Therapeutics Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Australia Traveler's Diarrhea Therapeutics Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. China Taiwan Traveler's Diarrhea Therapeutics Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Indonesia Traveler's Diarrhea Therapeutics Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Thailand Traveler's Diarrhea Therapeutics Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Malaysia Traveler's Diarrhea Therapeutics Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Latin America Traveler's Diarrhea Therapeutics Sales Market Share by Country (2021–2032)

Figure 55. Latin America Traveler's Diarrhea Therapeutics Revenue Market Share by Country (2021–2032)

Figure 56. Mexico Traveler's Diarrhea Therapeutics Revenue Growth Rate (US$ Million), 2021–2032

Figure 57. Brazil Traveler's Diarrhea Therapeutics Revenue Growth Rate (US$ Million), 2021–2032

Figure 58. Argentina Traveler's Diarrhea Therapeutics Revenue Growth Rate (US$ Million), 2021–2032

Figure 59. Middle East and Africa Traveler's Diarrhea Therapeutics Sales Market Share by Country (2021–2032)

Figure 60. Middle East and Africa Traveler's Diarrhea Therapeutics Revenue Market Share by Country (2021–2032)

Figure 61. Turkey Traveler's Diarrhea Therapeutics Revenue Growth Rate (US$ Million), 2021–2032

Figure 62. Saudi Arabia Traveler's Diarrhea Therapeutics Revenue Growth Rate (US$ Million), 2021–2032

Figure 63. UAE Traveler's Diarrhea Therapeutics Revenue Growth Rate (US$ Million), 2021–2032

Figure 64. Global Sales Market Share of Traveler's Diarrhea Therapeutics by Type (2021–2032)

Figure 65. Global Revenue Market Share of Traveler's Diarrhea Therapeutics by Type (2021–2032)

Figure 66. Global Traveler's Diarrhea Therapeutics Price (USD/Unit) by Type (2021–2032)

Figure 67. Global Sales Market Share of Traveler's Diarrhea Therapeutics by Application (2021–2032)

Figure 68. Global Revenue Market Share of Traveler's Diarrhea Therapeutics by Application (2021–2032)

Figure 69. Global Traveler's Diarrhea Therapeutics Price (USD/Unit) by Application (2021–2032)

Figure 70. Traveler's Diarrhea Therapeutics Value Chain

Figure 71. Channels of Distribution (Direct Vs Distribution)

Figure 72. Bottom-up and Top-down Approaches for This Report

Figure 73. Data Triangulation

Figure 74. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Travel Vaccines Market Insights Forecast to 2030

Drugs For Travelers Diarrhea TD Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Travel Sickness Drugs Market Insights Forecast to 2030

Global Anticholinergic Travel Sickness Drugs Market Insights Forecast to 2030

Global Antihistamines Travel Sickness Drugs Market Insights Forecast to 2030

Global TDS Monitors Market Research Report 2024

Global Amebiasis Therapeutics Market Insights Forecast to 2030

Global Amebiasis Treatment Market Insights Forecast to 2030

Global Amebiasis Market Insights Forecast to 2030

Global Amebiasis Drugs Market Insights Forecast to 2030

Difficile Associated Diarrhea Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Bacterial Enteric Disease Testing Market Research Report 2024

Global Irritable Bowel Syndrome with Diarrhea IBS D Drugs Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Global Gastrointestinal Drugs Market Research Report 2025

Global Travel Bidet Market Research Report 2024

Global Travel Health Service Market Research Report 2024

Global Rotavirus Infection Therapeutics Market Research Report 2024

Global Typhoid Fever Diagnostic Fluid Market Research Report 2024

Global Gastrointestinal Therapeutics Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions